Cleared Traditional

K971620 - QUANTA LITE RUBEOLA (MEASLES) IGG (FDA 510(k) Clearance)

Jul 1997
Decision
82d
Days
Class 1
Risk

K971620 is an FDA 510(k) clearance for the QUANTA LITE RUBEOLA (MEASLES) IGG. This device is classified as a Enzyme Linked Immunoabsorbent Assay, Rubeola Igg (Class I - General Controls, product code LJB).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on July 22, 1997, 82 days after receiving the submission on May 1, 1997.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3520. The Qualitative Detection Of Measles Specific Igg Antibodies In Serum Or Plasma..

Submission Details

510(k) Number K971620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 1997
Decision Date July 22, 1997
Days to Decision 82 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LJB — Enzyme Linked Immunoabsorbent Assay, Rubeola Igg
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3520
Definition The Qualitative Detection Of Measles Specific Igg Antibodies In Serum Or Plasma.